CJC 1295 (without DAC) CND10 10mg*10vials

CJC 1295 (DAC-free) CND10 10mg*10 vials is the most potent, fastest-acting, physiological growth hormone-releasing hormone (GHRH) analog research peptide in the CND series. It represents the top-tier saturated version of the CND series, a comprehensive upgrade from the basic CND2 and mid-range CND5. CND10 retains the pure, original non-DAC peptide structure, without albumin-binding modification, fully preserving its natural rapid metabolic clearance and ultra-clean, short-half-life pulsatile growth hormone release characteristics. Through comprehensive molecular activity optimization and achieving the industry's highest 10mg saturated concentration, CND10 provides maximum intensity pulsatile growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis activation and full-amplitude physiological phenotype, far exceeding the efficacy of low- and medium-dose CND series products. Specifically designed for high-dose threshold gradient studies, high-intensity pulsatile anabolic interventions, extreme acute lipid metabolism remodeling, and high-standard complex peptide synergistic effect validation, it is a top-tier core research material for preclinical studies of short-acting physiological endocrine and advanced metabolism in growth hormone peptide drugs. Product Functions and Research Value

In advanced laboratory studies, CJC 1295, without DAC CND10, triggers saturated, high-amplitude physiological pulsatile growth hormone secretion and a strong transient increase in IGF-1, perfectly mimicking the body's strongest natural intermittent endocrine pulsatile rhythm. Thanks to the classic non-DAC rapid clearance mechanism, excess peptides are rapidly and completely metabolized within a short half-life of approximately 30 minutes, thus avoiding hormone accumulation, continuous overstimulation, and endocrine desensitization—these core advantages distinguish short-acting GHRH from long-acting DAC-modified peptides. Compared to CND2 and CND5, CND10 achieves optimal efficacy in high-intensity pulsatile lean muscle hyperplasia, extremely acute lipolysis activation, high-load tissue damage repair, and the exploration of high-threshold endocrine dose-response mechanisms. While maintaining the true physiological regulatory logic, it outputs highly significant experimental phenotypes with maximum data discrimination, perfectly meeting the stringent data requirements of cutting-edge research, extreme gradient screening, and validation of high-dose peptide combination protocols.

Core Product Advantages

1. CND10 Flagship All-Around Upgrade: The top-tier saturated version of the CND series, with fully optimized molecular target affinity and activity. It retains 100% pure natural non-DAC physiological pulse characteristics while maximizing endocrine activation intensity, breaking through the efficacy limits of CND2 and CND5, suitable for high-threshold cutting-edge research.

2. Pure High-Fidelity Physiological Pulse Mechanism: Utilizes unmodified original peptide chains, without DAC albumin retention effects. Rapid metabolic clearance ensures zero hormone accumulation and maintains pituitary receptor sensitivity for a long time, perfectly mimicking the natural intermittent growth hormone secretion pattern in the human body, which long-acting peptides cannot replicate.

3. 10mg Saturated Concentration Upper Limit: Industry-leading all-around specification, twice as potent as CND5 and five times as potent as CND2. It completely solves the problem of insufficient phenotypic differentiation in low- and medium-dose versions, making it fully suitable for high-dose extreme gradient experiments and high-intensity acute metabolic intervention modeling. 4. Ultra-clean, low-interference endocrine regulation: Targeting the GHRH-GH-IGF-1 core pathway with ultra-high specificity, it induces purely physiological pulsatile secretion without interfering with stress hormones such as cortisol and prolactin, ensuring ultra-clean experimental variables and authoritative, reproducible research conclusions.

5. Pharmaceutical-grade superior quality assurance: Utilizing advanced aseptic vacuum freeze-drying technology, it retains 100% of the peptide activity peak. Each batch undergoes comprehensive HPLC high-purity testing and comes with a complete official COA certificate. Standard 10-bottle aseptic integrated packaging meets the needs of high-end laboratory cutting-edge research, key scientific research projects, top-tier drug preclinical development, and global high-end bulk wholesale procurement.

CJC 1295 (DAC-free) CND10 10mg*10 bottles is the flagship product of the CND series of short-acting physiological GHRH analog research peptides, with superior efficacy, and is the ultimate upgrade from the basic CND2 and intermediate-acting CND5. It adopts a pure natural peptide chain structure, contains no DAC, and has not undergone any albumin binding modification, thus fully preserving its core physiological characteristics.